The most significant cause of death
among p21 - null females (60 %) was
renal failure diagnosed by severe glomerulonephritis at an average age of 9.6 months (Table 1) ⇓.
Among the 50 trials, 30 were primary prevention trials (general populations, smokers and workers exposed to asbestos, patients with oesophageal dysplasia, male physicians, patients with non-melanoma skin cancer, postmenopausal women, patients undergoing chronic haemodialysis, patients with end stage
renal disease, ambulatory elderly women with vitamin D insufficiency, patients with chronic
renal failure, older people with femoral neck fractures, patients with diabetes mellitus, elderly women with a low serum 25 - hydroxyvitamin D concentration, health professionals, people with a high fasting plasma total homocysteine concentration, or kidney transplant recipients), and 20 were secondary prevention trials (patients with cardiovascular disease, coronary heart disease, acute myocardial infarction, unstable angina, transient ischaemic attack, stroke, angiographically proved coronary atherosclerosis, vascular disease, or aortic valve stenosis).
The illnesses covered vary
among insurers, but most insurers cover cancer, coronary artery bypass, heart attack, kidney /
renal failure, major organ transplant and paralytic stroke.